Published in Radiology on August 01, 2014
Hyaluronic acid-modified manganese-chelated dendrimer-entrapped gold nanoparticles for the targeted CT/MR dual-mode imaging of hepatocellular carcinoma. Sci Rep (2016) 0.78
CT Perfusion Characteristics Identify Metastatic Sites in Liver. Biomed Res Int (2015) 0.77
Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions. Radiology (2015) 0.76
Arg-Gly-Asp-D-Phe-Lys peptide-modified PEGylated dendrimer-entrapped gold nanoparticles for targeted computed tomography imaging of breast carcinoma. Nanomedicine (Lond) (2015) 0.76
Arterial input function placement effect on computed tomography lung perfusion maps. Quant Imaging Med Surg (2016) 0.75
Incidental tumor necrosis caused by the interventional alteration of hepatic arterial flow in patients with advanced hepatocellular carcinoma. Clin J Gastroenterol (2014) 0.75
High-Resolution Multispectral Optoacoustic Tomography of the Vascularization and Constitutive Hypoxemia of Cancerous Tumors. Neoplasia (2016) 0.75
Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma. Eur Radiol (2016) 0.75
A semi-automatic method for the extraction of the portal venous input function in quantitative dynamic contrast-enhanced CT of the liver. Br J Radiol (2017) 0.75
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer (2009) 77.71
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
Nonrigid registration using free-form deformations: application to breast MR images. IEEE Trans Med Imaging (1999) 21.56
Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med (1999) 17.03
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med (2004) 9.80
Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis (2010) 9.73
Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab (1983) 9.59
Deformable templates using large deformation kinematics. IEEE Trans Image Process (1996) 7.62
Molecular imaging. Radiology (2001) 5.67
Penalized weighted least-squares approach to sinogram noise reduction and image reconstruction for low-dose X-ray computed tomography. IEEE Trans Med Imaging (2006) 3.76
Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol (1986) 2.93
Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density. Radiology (2004) 2.68
Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis (2010) 2.46
Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer (2009) 2.38
Cerebral blood flow determination by rapid-sequence computed tomography: theoretical analysis. Radiology (1980) 2.19
Liver metastases: early detection based on abnormal contrast material enhancement at dual-phase helical CT. Radiology (1997) 2.13
Perfusion CT for the assessment of tumour vascularity: which protocol? Br J Radiol (2003) 2.03
Perfusion imaging of the liver: current challenges and future goals. Radiology (2005) 1.95
Advanced hepatocellular carcinoma: CT perfusion of liver and tumor tissue--initial experience. Radiology (2007) 1.87
Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review. Eur J Radiol (1999) 1.87
Quantitative tumor perfusion assessment with multidetector CT: are measurements from two commercial software packages interchangeable? Radiology (2007) 1.80
Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: a proof of principle. J Hepatol (2010) 1.77
Application of CT in the investigation of angiogenesis in oncology. Acad Radiol (2000) 1.76
Tracer kinetic modelling in MRI: estimating perfusion and capillary permeability. Phys Med Biol (2011) 1.75
A systematic approach to the development of fluorescent contrast agents for optical imaging of mouse cancer models. Anal Biochem (2007) 1.70
Body perfusion CT: technique, clinical applications, and advances. Radiol Clin North Am (2009) 1.67
In vivo assessment of neovascularization of liver metastases using perfusion CT. Br J Radiol (1998) 1.67
Potential role of doppler perfusion index in selection of patients with colorectal cancer for adjuvant chemotherapy. Lancet (2000) 1.58
Molecular ultrasound imaging: current status and future directions. Clin Radiol (2010) 1.51
Tissue mean transit time from dynamic computed tomography by a simple deconvolution technique. Invest Radiol (1983) 1.51
Functional images of hepatic perfusion obtained with dynamic CT. Radiology (1993) 1.51
Hypervascular liver tumors: low tube voltage, high tube current multi-detector row CT for enhanced detection--phantom study. Radiology (2008) 1.44
Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment. Abdom Imaging (2006) 1.41
Perfusion magnetic resonance imaging of the liver. World J Gastroenterol (2010) 1.40
Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography. Eur Radiol (2012) 1.38
Hypervascular liver tumors: low tube voltage, high tube current multidetector CT during late hepatic arterial phase for detection--initial clinical experience. Radiology (2009) 1.34
Monitoring response to antiangiogenic treatment and predicting outcomes in advanced hepatocellular carcinoma using image biomarkers, CT perfusion, tumor density, and tumor size (RECIST). Invest Radiol (2012) 1.33
A model for capillary exchange. Am J Physiol (1966) 1.32
Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. Clin Sci (Lond) (2000) 1.31
Colorectal tumor vascularity: quantitative assessment with multidetector CT--do tumor perfusion measurements reflect angiogenesis? Radiology (2008) 1.29
Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma. Oncologist (2008) 1.27
Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. Radiology (2001) 1.27
Molecular ultrasound assessment of tumor angiogenesis. Angiogenesis (2010) 1.26
Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements. Eur J Nucl Med Mol Imaging (2010) 1.21
Hepatic perfusion in a tumor model using DCE-CT: an accuracy and precision study. Phys Med Biol (2008) 1.16
The application of genomic and proteomic technologies in predictive, preventive and personalized medicine. Vascul Pharmacol (2006) 1.13
Improved diagnosis of hepatic perfusion disorders: value of hepatic arterial phase imaging during helical CT. Radiographics (2001) 1.12
The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma. Am Surg (2003) 1.12
A phase I surrogate endpoint study of SU6668 in patients with solid tumors. Invest New Drugs (2004) 1.12
Functional CT quantification of tumor perfusion after transhepatic arterial embolization in a rat model. Radiology (2005) 1.10
Reproducibility of CT perfusion parameters in liver tumors and normal liver. Radiology (2011) 1.09
Hepatic metastases: in vivo assessment of perfusion parameters at dynamic contrast-enhanced MR imaging with dual-input two-compartment tracer kinetics model. Radiology (2008) 1.08
Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses. AJR Am J Roentgenol (2010) 1.08
Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound. Invest Radiol (2012) 1.08
Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr (1995) 1.06
Colorectal cancer: diagnostic potential of CT measurements of hepatic perfusion and implications for contrast enhancement protocols. Radiology (1997) 1.06
Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization. Acad Radiol (2008) 1.05
Quantitative CT color mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma. Radiology (2009) 1.05
3-D deformable image registration: a topology preservation scheme based on hierarchical deformation models and interval analysis optimization. IEEE Trans Image Process (2005) 1.04
Angiogenesis of renal cell carcinoma: perfusion CT findings. Abdom Imaging (2009) 1.04
Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging. Eur Radiol (2011) 1.03
Targeted contrast-enhanced ultrasound: an emerging technology in abdominal and pelvic imaging. Gastroenterology (2011) 1.02
Head and neck squamous cell carcinoma: CT perfusion can help noninvasively predict intratumoral microvessel density. Radiology (2009) 1.02
Role of angiogenesis in the development and growth of liver metastasis. Ann Surg Oncol (2002) 1.01
CT perfusion in oncology: how to do it. Cancer Imaging (2010) 1.00
Detection of pancreatic tumors, image quality, and radiation dose during the pancreatic parenchymal phase: effect of a low-tube-voltage, high-tube-current CT technique--preliminary results. Radiology (2010) 1.00
Ultrasound assessment of normal renal dimensions. J Ultrasound Med (1982) 0.99
The role of perfusion CT as a follow-up modality after transcatheter arterial chemoembolization: an experimental study in a rabbit model. Invest Radiol (2010) 0.98
Characterization of hepatocellular carcinoma and colorectal liver metastasis by means of perfusion MRI. J Magn Reson Imaging (2008) 0.98
Hepatocelluar nodules in liver cirrhosis: hemodynamic evaluation (angiography-assisted CT) with special reference to multi-step hepatocarcinogenesis. Abdom Imaging (2011) 0.96
Total-liver-volume perfusion CT using 3-D image fusion to improve detection and characterization of liver metastases. Eur Radiol (2008) 0.96
Quantification of angiogenesis by functional computed tomography in a Matrigel model in rats. Acad Radiol (2004) 0.95
CT color mapping of the arterial enhancement fraction of VX2 carcinoma implanted in rabbit liver: comparison with perfusion CT. AJR Am J Roentgenol (2011) 0.95
Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice. Invest Radiol (2012) 0.94
Hepatic CT perfusion measurements: a feasibility study for radiation dose reduction using new image reconstruction method. Eur J Radiol (2012) 0.93
Perfusion CT findings in patients with metastatic carcinoid tumors undergoing bevacizumab and interferon therapy. AJR Am J Roentgenol (2011) 0.92
Early therapy evaluation of combined cetuximab and irinotecan in orthotopic pancreatic tumor xenografts by dynamic contrast-enhanced magnetic resonance imaging. Mol Imaging (2011) 0.92
Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor. World J Gastroenterol (2010) 0.91
Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas. Invest Radiol (2012) 0.90
Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization. Eur J Radiol (2008) 0.88
Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging. J Comput Assist Tomogr (2011) 0.88
Liver perfusion imaging in patients with primary and metastatic liver malignancy: prospective comparison between 99mTc-MAA spect and dynamic CT perfusion. Acad Radiol (2012) 0.88
Perfusion computed tomography in patients with hepatocellular carcinoma treated with thalidomide: initial experience. J Comput Assist Tomogr (2011) 0.87
The quandary over liver transplantation for hepatocellular carcinoma: the greater sin? Liver Transpl (2002) 0.87
Perfusion characterization of liver metastases from endocrine tumors: Computed tomography perfusion. World J Radiol (2010) 0.87
CT perfusion for determination of pharmacologically mediated blood flow changes in an animal tumor model. Radiology (2007) 0.87
Changes of intratumoral microvessels and blood perfusion during establishment of hepatic metastases in mice. Radiology (2007) 0.86
Hepatic metastases: the value of quantitative assessment of contrast enhancement on computed tomography. Eur J Radiol (1999) 0.86
The portal component of hepatic perfusion measured by dynamic CT: an indicator of hepatic parenchymal damage. Dig Dis Sci (1999) 0.86
Functional CT imaging of prostate cancer. Phys Med Biol (2003) 0.86
Quantitative colorectal cancer perfusion measurement by multidetector-row CT: does greater tumour coverage improve measurement reproducibility? Br J Radiol (2006) 0.86
Perfusion CT in colorectal cancer: comparison of perfusion parameters with tumor grade and microvessel density. Korean J Radiol (2012) 0.85
Perfusion CT and US of colorectal cancer liver metastases: a correlative study of two dynamic imaging modalities. Ultrasound Med Biol (2010) 0.84
Hepatic metastases. Radiol Clin North Am (1998) 0.84
Does the presence of distant and local malignancy alter parenchymal perfusion in apparently disease-free areas of the liver? Dig Dis Sci (2001) 0.83
[Effect of perfusion CT scan on hepatic hemodynamic changes in rats with liver micrometastases]. Ai Zheng (2006) 0.83
Intermodality comparison between 3D perfusion CT and 18F-FDG PET/CT imaging for predicting early tumor response in patients with liver metastasis after chemotherapy: preliminary results of a prospective study. Eur J Radiol (2012) 0.83
Single-level dynamic spiral CT of hepatocellular carcinoma: correlation between imaging features and density of tumor microvessels. World J Gastroenterol (2004) 0.82
Dynamic contrast-enhanced CT of head and neck tumors: comparison of first-pass and permeability perfusion measurements using two different commercially available tracer kinetics models. Acad Radiol (2008) 0.80
Bladder transitional cell carcinoma: correlation of contrast enhancement on computed tomography with histological grade and tumour angiogenesis. Clin Radiol (2005) 0.80
Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). Radiology (2010) 2.32
Quantification and monitoring of inflammation in murine inflammatory bowel disease with targeted contrast-enhanced US. Radiology (2011) 1.64
Tumor angiogenic marker expression levels during tumor growth: longitudinal assessment with molecularly targeted microbubbles and US imaging. Radiology (2011) 1.61
Incidentally discovered solid pancreatic masses: imaging and clinical observations. Abdom Imaging (2012) 1.47
Molecular body imaging: MR imaging, CT, and US. part I. principles. Radiology (2012) 1.33
Thoracic aorta: motion artifact reduction with retrospective and prospective electrocardiography-assisted multi-detector row CT. Radiology (2002) 1.31
Three-dimensional photoacoustic imaging using a two-dimensional CMUT array. IEEE Trans Ultrason Ferroelectr Freq Control (2009) 1.31
Comparison of optical bioluminescence reporter gene and superparamagnetic iron oxide MR contrast agent as cell markers for noninvasive imaging of cardiac cell transplantation. Mol Imaging Biol (2008) 1.27
Molecular ultrasound assessment of tumor angiogenesis. Angiogenesis (2010) 1.26
Adrenal angiomyolipoma in lymphangioleiomyomatosis. Eur Radiol (2006) 1.26
Early diagnosis of ovarian carcinoma: is a solution in sight? Radiology (2011) 1.16
Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model. Cancer Res (2013) 1.12
Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging. Invest Radiol (2011) 1.10
Molecular body imaging: MR imaging, CT, and US. Part II. Applications. Radiology (2012) 1.09
Ultrasound for molecular imaging and therapy in cancer. Quant Imaging Med Surg (2012) 1.09
Imaging of VEGF receptor in a rat myocardial infarction model using PET. J Nucl Med (2008) 1.09
Ultrasound imaging of bowel pathology: technique and keys to diagnosis in the acute abdomen. AJR Am J Roentgenol (2011) 1.08
Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1. Gastroenterology (2013) 1.05
Ultrasound-mediated gene delivery with cationic versus neutral microbubbles: effect of DNA and microbubble dose on in vivo transfection efficiency. Theranostics (2012) 1.05
Cationic versus neutral microbubbles for ultrasound-mediated gene delivery in cancer. Radiology (2012) 1.03
Antioxidants improve early survival of cardiomyoblasts after transplantation to the myocardium. Mol Imaging Biol (2009) 1.02
Targeted contrast-enhanced ultrasound: an emerging technology in abdominal and pelvic imaging. Gastroenterology (2011) 1.02
Optimal vascular and parenchymal contrast enhancement: the current state of the art. Radiol Clin North Am (2009) 1.02
Pharmacokinetically stabilized cystine knot peptides that bind alpha-v-beta-6 integrin with single-digit nanomolar affinities for detection of pancreatic cancer. Clin Cancer Res (2011) 1.01
β-Catenin regulates hepatic mitochondrial function and energy balance in mice. Gastroenterology (2012) 1.00
Intraoperative ultrasound of the pancreas. Ultrasound Q (2009) 1.00
Experience of 4 years with open MR defecography: pictorial review of anorectal anatomy and disease. Radiographics (2002) 0.98
Informatics in radiology: RADTF: a semantic search-enabled, natural language processor-generated radiology teaching file. Radiographics (2010) 0.97
Acoustic and photoacoustic molecular imaging of cancer. J Nucl Med (2013) 0.96
Fast microbubble dwell-time based ultrasonic molecular imaging approach for quantification and monitoring of angiogenesis in cancer. Quant Imaging Med Surg (2012) 0.96
Pitfalls in sonographic evaluation of thyroid abnormalities. Semin Ultrasound CT MR (2013) 0.96
Ultrasound molecular imaging contrast agent binding to both E- and P-selectin in different species. Invest Radiol (2012) 0.95
Aortoenteric fistulas: spectrum of CT findings. Abdom Imaging (2013) 0.95
Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detection. Radiology (2014) 0.95
Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice. Invest Radiol (2012) 0.94
Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma. Cancer Biol Ther (2012) 0.94
Laparoscopic radical nephrectomy after shrinkage of a caval tumor thrombus with sunitinib. Nat Rev Urol (2009) 0.94
Multidetector-row helical CT: analysis of time management and workflow. Eur Radiol (2001) 0.94
Molecular imaging of inflammation in inflammatory bowel disease with a clinically translatable dual-selectin-targeted US contrast agent: comparison with FDG PET/CT in a mouse model. Radiology (2013) 0.94
Adenocarcinoma of the uncinate process of the pancreas: MDCT patterns of local invasion and clinical features at presentation. Eur Radiol (2011) 0.93
Traumatic injuries: imaging of abdominal and pelvic injuries. Eur Radiol (2002) 0.93
Quantitative assessment of tumor angiogenesis using real-time motion-compensated contrast-enhanced ultrasound imaging. Angiogenesis (2012) 0.91
Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer. Invest Radiol (2015) 0.89
Ultrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer model. Clin Cancer Res (2014) 0.89
Pathways of extrapancreatic perineural invasion by pancreatic adenocarcinoma: evaluation with 3D volume-rendered MDCT imaging. AJR Am J Roentgenol (2010) 0.89
A bayesian network for differentiating benign from malignant thyroid nodules using sonographic and demographic features. AJR Am J Roentgenol (2011) 0.88
Ultrasound of thyroid nodules. Neuroimaging Clin N Am (2008) 0.87
Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging. Radiology (2009) 0.87
Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging. Radiology (2005) 0.86
Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Am J Clin Oncol (2012) 0.86
Ultrasound and microbubble-mediated gene delivery in cancer: progress and perspectives. Invest Radiol (2013) 0.86
Physiologic, histologic, and imaging features of retained products of conception. Radiographics (2013) 0.86
Thin-section CT of the lung: does electrocardiographic triggering influence diagnosis? Radiology (2003) 0.85
Quantitatively defining washout in hepatocellular carcinoma. AJR Am J Roentgenol (2013) 0.84
Hepatic epithelioid hemangioendothelioma. Dig Dis Sci (2010) 0.83
Intermodality comparison between 3D perfusion CT and 18F-FDG PET/CT imaging for predicting early tumor response in patients with liver metastasis after chemotherapy: preliminary results of a prospective study. Eur J Radiol (2012) 0.83
Reporter gene imaging following percutaneous delivery in swine moving toward clinical applications. J Am Coll Cardiol (2008) 0.83
Classification of hypervascular liver lesions based on hepatic artery and portal vein blood supply coefficients calculated from triphasic CT scans. J Digit Imaging (2015) 0.82
Effects of ECG gating and postprocessing techniques on 3D MDCT of the bronchial tree. AJR Am J Roentgenol (2004) 0.81
Assessment of the abdominal aorta and its visceral branches by contrast-enhanced dynamic volumetric hepatic parallel magnetic resonance imaging: feasibility, reliability and accuracy. Eur Radiol (2006) 0.80
Mapping of hepatic vascular anatomy: dynamic contrast-enhanced parallel MR imaging compared with 64 detector row CT. Radiology (2007) 0.80
Fetus in fetu: 11 fetoid forms in a single fetus: review of the literature and imaging. J Ultrasound Med (2008) 0.80
3-D Deep Penetration Photoacoustic Imaging with a 2-D CMUT Array. Proc IEEE Ultrason Symp (2010) 0.79
Recurrent lower-limb varicose veins: effect of direct contrast-enhanced three-dimensional MR venographic findings on diagnostic thinking and therapeutic decisions. Radiology (2008) 0.79
Assessment of aortoiliac and renal arteries: MR angiography with parallel acquisition versus conventional MR angiography and digital subtraction angiography. Radiology (2007) 0.78
Multidetector computed tomography triphasic evaluation of the liver before transplantation: importance of equilibrium phase washout and morphology for characterizing hypervascular lesions. J Comput Assist Tomogr (2012) 0.78
MR angiography with parallel acquisition for assessment of the visceral arteries: comparison with conventional MR angiography and 64-detector-row computed tomography. Eur Radiol (2009) 0.78
Evaluation of periampullary pathology with CT volumetric oblique coronal reformations. AJR Am J Roentgenol (2009) 0.78
New technologies in clinical ultrasound. Semin Roentgenol (2013) 0.77
A Bayesian classifier for differentiating benign versus malignant thyroid nodules using sonographic features. AMIA Annu Symp Proc (2008) 0.76
A Controlled Vocabulary to Represent Sonographic Features of the Thyroid and its application in a Bayesian Network to Predict Thyroid Nodule Malignancy. Summit on Translat Bioinforma (2009) 0.75
Relapsed Extramedullary Multiple Myeloma Presenting as Bilateral Solid Perirenal Masses. Radiol Case Rep (2015) 0.75
Atypical thyroid cancers on sonography. Ultrasound Q (2015) 0.75
Duplex Doppler Ultrasound of the Hepatic Artery: A Window to Diagnosis of Diffuse Liver Pathology. Ultrasound Q (2016) 0.75
Survey Study on the Experience, Practice Patterns, and Preferences of the Fellows of the Society of Radiologists in Ultrasound for Evaluation and Management of Gallbladder Polyps Detected With Ultrasound. Ultrasound Q (2022) 0.75
The elusive parathyroid adenoma: techniques for detection. Ultrasound Q (2013) 0.75
Secondary aortoenteric fistula: active bleeding detected with multi-detector-row CT. Eur Radiol (2002) 0.75
An unusual imaging and clinical presentation of papillary thyroid carcinoma. J Ultrasound Med (2008) 0.75